AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gleznor M 60mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Costa Rich Pharmaceuticals

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Gleznor M 60mg/500mg Tablet

Diabetica Duo 60mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Administer Diabetica Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar response. Continued use, even with controlled glucose or feeling well, is crucial. Discontinuing without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including a healthy diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are essential to manage hypoglycemia. Alcohol consumption should be minimized due to its potential to exacerbate low blood sugar. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to monitor blood cell counts and liver function.

Primary Ingredients of Gleznor M 60mg/500mg Tablet

There is no text provided to rephrase.

Uses of Gleznor M 60mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Gleznor M 60mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gleznor M 60mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Gleznor M 60mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Gleznor M 60mg/500mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Gleznor M 60mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Gleznor M 60mg/500mg Tablet works:

Gleznor M tablets (60mg/500mg) contain gliclazide and metformin, two medications used to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol ingestion and Gleznor M 60mg/500mg Tablet use poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Gleznor M 60mg/500mg tablets is contraindicated during pregnancy due to established risk to the fetus. A physician might exceptionally prescribe it in life-threatening circumstances where potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Gleznor M 60mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Gleznor M 60mg/500mg tablets, as dose modification may be necessary. Individuals with severe kidney disease should avoid this medication. Close monitoring of kidney function is recommended during treatment. A physician's consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Gleznor M 60mg/500mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. A reduced initial dose is typically prescribed for individuals with mild to moderate liver disease; the medication is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Gleznor M 60mg/500mg Tablet :

Should you forget to take your Gleznor M 60mg/500mg Tablet, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Gleznor M 60mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gleznor M 60mg/500mg Tablet

Gleznor M 60mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Gleznor M 60mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Gleznor M 60mg/500mg Tablets can cause low blood sugar (hypoglycemia), resulting in nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Gleznor M 60mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Gleznor M 60mg/500mg Tablets and seek immediate medical attention.
Prolonged Gleznor M 60mg/500mg Tablet use can lead to vitamin B12 deficiency by impairing its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Gleznor M 60mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Gleznor M 60mg/500mg tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Gleznor M 60mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Gleznor M 60mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Gleznor M 60mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Gleznor M 60mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Gleznor M 60mg/500mg Tablets and seek immediate medical attention.
Prolonged Gleznor M 60mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Gleznor M 60mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Gleznor M 60mg/500mg tablets with alcohol is unsafe. Alcohol can worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Gleznor M 60mg/500mg Tabl...
70
MRP 85
17% off